Test Your Knowledge of HCC Presented at ASCO 2024!
Do you remember the HCC research presented at ASCO 2024? Test your knowledge and see how you rank!
Read More
Meeting Coverage
Test More of Your Knowledge of eNSCLC From ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test more of your knowledge with new questions and see how you rank!
Read More
Test More of Your Knowledge of CLL Presented at ASCO 2024!
Do you remember the CLL research presented at ASCO 2024? Test your knowledge with new questions and see how you rank!
Read More
Test Your Knowledge of CLL Presented at ASCO 2024!
Do you remember the CLL research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read More
Test Your Knowledge of eNSCLC Presented at ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read More
ASCO 2024 eBook on eNSCLC
A curated eBook featuring ASCO 2024 eNSCLC-focused studies, findings, and expert opinions.
Read More
ASCO 2024 eBook on CLL
A curated eBook featuring ASCO 2024 CLL-focused studies, findings, and expert opinions.
Read More
ASCO 2024 eBook on HCC
A curated eBook featuring ASCO 2024 HCC-focused studies, findings, and expert opinions.
Read More
CTNNB1 Alterations Affect Outcomes in Patients With HCC
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Read More
Why Do Physicians Order NSCLC Biomarker Tests, and Who Gets Appropriate Targeted Therapy?
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read More
Targeted Sequencing Adds Value to FISH for Detecting Genetic Alterations in CLL
Researchers evaluated whether targeted next-generation sequencing was comparable to fluorescence in situ hybridization for detecting genetic alterations in CLL.
Read More
What Do You Know About Multiple Myeloma?
Do you remember the multiple myeloma research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read More
ASCO 2024 eBook on Multiple Myeloma
A curated eBook featuring ASCO 2024 multiple myeloma-focused studies, findings, and expert opinions.
Read More
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy
Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter transformation.
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
Spotlight On the 42nd ASRS Annual Scientific Meeting July 17-20
Immerse yourself in retinal science advancements, therapeutics, innovation and fellowship at the 42nd ASRS Annual Scientific Meeting July 17-20, 2024.
Read More
Black Patients With HCC Less Likely to Receive Curative Treatment
Black patients with HCC are less likely than White patients to receive curative treatment.
Read More
What Do You Remember from ASRS 2023?
A quiz based on the latest from ASRS on Retinal Vascular Disease news and studies.
Read More
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma
High-dose melphalan conditioning confers survival benefits in patients with extramedullary and non-extramedullary multiple myeloma.
Read More
ASRS 2024 Schedule at a Glance
Take a look at the schedule for ASRS 2024 Annual Meeting.
Read More